The lymphocyte component of the immune system is divided into B lymphocytes and T lymphocytes. B lymphocytes produce antibodies (humoral immunity) via maturation into plasma cells, and T lymphocytes kill other cells or organisms (cellular immunity). A traditional immunological paradigm is that B lymphocyte and T lymphocyte interactions are a one-way phenomenon, with T lymphocytes helping to induce the terminal differentiation of B lymphocytes into immunoglobulin class-switched plasma cells. A deficiency of T lymphocytes was reported to result in defective B lymphocyte function. However, evidence for a reciprocal interaction between B and T lymphocytes is emerging, with B lymphocytes influencing the differentiation and effector function of T lymphocytes. For example, B lymphocytes have been shown to induce direct tolerance of antigen-specific CD8 + T lymphocytes and induce T lymphocytes anergy via transforming growth factor-beta (TGF-β) production. The present study showed that LPS-stimulated B lymphocytes inhibited the differentiation of Th1 lymphocytes by inhibiting the production of interleukin-12 (IL-12) from dendritic cells. An interaction between the B lymphocytes and dendritic cells was not needed for this inhibition, and the B lymphocytes did not alter dendritic cell maturation. B lymphocyte-derived soluble factor (BDSF) suppressed the LPS-induced IL-12p35 transcription in the dendritic cells. Overall, these results point to a novel B lymphocyte-mediated immune suppressive mechanism. The findings cast doubt on the traditional paradigm of immunological interactions involving B lymphocyte and T lymphocyte interactions. 
A novel IL-12-inhibiting activity secreted by LPS stimulated B lymphocytes. Dendritic cells and unstimuated B lymphocytes (A, B-cell) and LPS stimulated B lymphocytes (B, LPS-B cell) were co-cultured for 24 hr, and IL-12p35 and IL-12p70 production were measured by ELISA. Dendritic cells (DCs) were generated from mouse bone marrow heamaropoietic stem cell, by GM-CSF and IL-4 treatment for 7 days. DCs were greater than 95% pure that expressed the appropriate markers such as CD11c, CD86, and MHC Class II.(data not shown) B lymphocytes were isolated with anti-CD19 microbead (Miltenyi) from mouse spleen. DCs (0.3×10 6 ) and B lymphocytes were co-cultured or separated in a transwell chamber device with B lymphocytes in the upper chamber and mDCs in the lower chamber, in ratios of DC:B of 1:2 (2x) or 1:3 (3x), for 24 hr in the presence or absence of LPS (1 μg/ml) in both chambers. Cell-free culture supernatant was analyzed for cytokines by specific ELISAs. Unstimulated and LPS stimulated B lymphocytes did not produce any detectable IL-12p40 and p70 (not shown). Data represent summary of three donors each with SD. *<0.05. Mouse bone marrow-derived dendritic cells were cultured with naïve CD4+ T lymphocytes in the presence of culture supernatant from LPS-stimulated B lymphocytes (S-sup) for 24 hr and followed by analysis of IFN-γ production was measured by ELISA. Dendritic cells (DCs) were generated from mouse bone marrow heamatopoietic stem cell, by GM-CSF and IL-4 treatment for 7 days. B lymphocytes and naïve CD4+ T lymphocytes were isolated from mice spleen by micro bead as mentioned in material and methods. DCs were stimulated by LPS with or without culture supernatant from LPSstimulated B lymphocytes (S-sup) for 6 hr, and isolated naïve CD4+ T lymphocytes were cultured with DCs for 24 hr. IFN-γ production was measured from supernatant. 
